$27.62
-0.57 (-2.02%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+263.9% upside
Low Target
$77.00
Average Target
$100.50
High Target
$121.27
Current Price
$27.62
Current
$27.62
$27.62
Target
$100.50
$100.50
$77.00
$100.50 avg
$121.27
Scenario Analysis
Bear Case
$77.00
178.8%
Low target
Base Case
$100.50
+263.9%
Avg target
Bull Case
$121.27
+339.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$31.74
-13.0% from high
52-Week Low
$8.84
+212.4% from low
50-Day SMA
$22.13
+24.8% vs SMA
200-Day SMA
$15.14
+82.4% vs SMA
RSI (14)
36.6
Neutral
Target vs 52W High
$100.50
+216.7% vs high
Next Earnings Report
Aug 12, 2026 · After Market Close
4d
until earnings
EPS Est: $-0.92
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -43.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.3% |
| BIIB | Buy | 44 | 64% | $91.45 | -55.7% |